Loading…

Synthesis and antimicrobial evaluation of new 2-substituted 5,7-di- tert-butylbenzoxazoles

Various synthetic pathways of the 30 novel 2-substituted 5,7-di- tert-butylbenzoxazoles as new potential antimicrobial drugs are discussed. The 28 intermediates are described as well. The compounds were characterized by 1H and 13C NMR spectra, MS spectra, IR/UV spectra and by means of CHN analysis....

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry 2006-09, Vol.14 (17), p.5850-5865
Main Authors: Vinsova, Jarmila, Cermakova, Katerina, Tomeckova, Alexandra, Ceckova, Martina, Jampilek, Josef, Cermak, Pavel, Kunes, Jiri, Dolezal, Martin, Staud, Frantisek
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Various synthetic pathways of the 30 novel 2-substituted 5,7-di- tert-butylbenzoxazoles as new potential antimicrobial drugs are discussed. The 28 intermediates are described as well. The compounds were characterized by 1H and 13C NMR spectra, MS spectra, IR/UV spectra and by means of CHN analysis. The purity of the final compounds was checked by HPLC and their lipophilicity (log K) was also determined by means of RP-HPLC. In the present study, the correlation between RP-HPLC retention parameter log K (the logarithm of capacity factor K) and various calculated log P data is shown. The target compounds were tested for their in vitro antimycobacterial activity. Several compounds showed antituberculotic activity comparable with or higher than the standard isoniazide. In vitro cytotoxicity testing of the most active benzoxazoles and isoniazide as a reference drug was performed using MTT assay and compared with isoniazide as a reference drug. Structure–activity relationships among the chemical structures, the physical properties and the biological activities of the evaluated compounds are discussed in the article.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2006.05.030